Quantcast

Johnson & Johnson Too Rich For You? Try This High-Yielding Pharma Stock Instead

Posted On January 30, 2017 10:49 pm
By:

While Johnson & Johnson is famous as one of the highest-quality, and safest dividend growth investment you can make, it’s current valuation may give many investors pause. Which is why you should consider this faster growing, higher-yielding, grade A blue chip Pharma stock instead.

Continue Reading Here

About author

Dividend Sensei
Dividend Sensei

I’m an Army veteran and former energy dividend writer for The Motley Fool. I currently write for both Seeking Alpha, Simply Safe Dividends, Investorplace.com, and TheStreet.com.

My goal is to help all people learn how to harness the awesome power of dividend growth investing to achieve their financial dreams, and enrich their lives. With 20 years of investing experience, I’ve learned what works and more importantly, what doesn’t, when it comes to building long-term wealth and income streams. I’m currently on an epic quest to build a broadly diversified, high-quality, high-yield dividend growth portfolio that:

1. Pays a 4% to 5% yield
2. Offers 9% to 10% annual dividend growth
3. Pays dividends AT LEAST on a weekly, but preferably, daily basis

Related Articles